Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

In-situ hybridization detection kit for Spink1 genes and detection method and application thereof

A detection kit and in situ hybridization technology, applied in the field of kits, can solve the problems of difficulty in distinguishing BPH from Pca, lack of specificity and increase of PSA, and achieve the effects of high sensitivity, strong specificity and convenient operation.

Inactive Publication Date: 2011-03-23
SUZHOU FUYING GENE TECH
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Recently, the diagnostic accuracy of PSA has been discussed by more and more literatures. In the past, people have used prostate-specific antigen (PSA) as a marker of prostate cancer (Pca), but PSA lacks specificity. In the case of benign prostatic hyperplasia (BPH) PSA also increases
Especially when PSA is in the range of 4-10ng / L, it is difficult to distinguish BPH from Pca

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • In-situ hybridization detection kit for Spink1 genes and detection method and application thereof
  • In-situ hybridization detection kit for Spink1 genes and detection method and application thereof
  • In-situ hybridization detection kit for Spink1 genes and detection method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] An in situ hybridization detection kit for Spink1 gene, comprising a hybridization probe, a marker and a synergist, wherein the sequence of the hybridization probe is shown in SEQ ID NO.1. Hybridization probes were labeled with digoxigenin. The composition of other liquids and specimens in the kit is as follows:

[0047] Digestive solution 100μl / tube 1 tube / box Colorless transparent liquid

[0048] Protective solution 100μl / tube 1 tube / box Colorless transparent liquid

[0049] Pre-hybridization solution 1300μl / tube 2 tubes / box Colorless transparent liquid

[0050] Sense hybridization solution 10μl / tube 1 tube / box Colorless transparent liquid

[0051] Antisense hybridization solution 10μl / tube 1 tube / box Colorless transparent liquid

[0052] Blocking solution 1000μl / tube 1 tube / box Colorless transparent liquid

[0053] Alkaline phosphatase antibody 1μl / tube 1 tube / box Colorless transparent liquid

[0054] Chromogen A 175μl / tube 1 tube / box Yellow liquid

[0055] Ch...

Embodiment 2

[0097] A Spink1 gene in situ hybridization detection method and its kit application

[0098] 1. Specimen processing

[0099] 1. Use a 10ml centrifuge tube to fill 4.5ml of lymphocyte separation solution, then slowly add 3ml of anticoagulated blood into the centrifuge tube containing lymphocyte separation solution (blood: lymphocyte separation solution = 1:1.5), and centrifuge at 2000r / min 10min;

[0100] 2. Take the white blood cells in the middle layer into another centrifuge tube, then add about twice the amount of 1× buffer I to this tube, mix well, and centrifuge at 1500g / min for 10min;

[0101] 3. Discard the supernatant. Add about twice the 1× buffer I to the precipitate, mix well, and centrifuge at 1500g / min for 10min;

[0102] 4. Discard the supernatant, and absorb the excess liquid from the mouth of the test tube with paper towels. Then the precipitate was made into a suspension, dropped on a glass slide, and allowed to dry naturally. (Hospitals with conditions ca...

Embodiment 3

[0137] Parallel experiments between the detection of prostate cancer disease with the Spink1 gene kit and the detection of prostate cancer disease with the ACP1 gene kit.

[0138] In order to scientifically evaluate the specificity, sensitivity and accuracy of the above genes in prostate cancer. We used the method of parallel experiments to detect the mRNA of the above genes at the same time. The detection technology used nucleic acid in situ hybridization technology to detect the Spink1 gene and ACP1 (ACP1 (acid phosphatase 1), NR_024080 ) mRNA of the gene (nucleic acid in situ hybridization, immunohistochemical staining, microscopic counting, result reporting, etc. all adopt the same methods, steps and reagents as the in situ hybridization techniques of Example 1 and Example 2). It was found that the expression level of Spink1 gene in prostate cancer patients was higher than that of ACP1 gene in patients with the same disease. The results showed that the specificity, sensit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an in-situ hybridization detection kit for Spink1 (serine peptidase inhibitor, Kazal type 1) genes, which comprises a hybridization probe and a marker, wherein the sequence of the hybridization probe is expressed as SEQ ID No.1. The invention also provides an in-situ hybridization detection method for the Spink1 genes. In addition, the invention also provides application of the kit in preparation of a medicament for detecting prostatic cancer diseases. The kit provided by the invention has the advantages of high sensitivity and strong specificity. The detection method is convenient and simple to operate, and can be universally used and popularized in hospitals of above district level.

Description

【Technical field】 [0001] The present invention relates to a kit, in particular to a Spink1 gene in situ hybridization detection kit and its detection method and application 【Background technique】 [0002] Prostate cancer (prostatic cancer) is the most common malignant tumor in the male reproductive system. The incidence increases with age, and its incidence has obvious regional differences. It is higher than lung cancer in Western Europe and North America. It is the second leading cause of cancer death in men. 1 person. The incidence rate in my country was low in the past, but due to the aging population, the incidence rate has increased in recent years, from 1.7 per 100,000 people in 1993 to 4.55 per 100,000 in 2000, and to 7.9 in 2005. Although this incidence rate is relatively low compared with other tumors, for urban men, the incidence rate of prostate cancer ranks the tenth among all tumors, which should be highly concerned. The incidence of prostate cancer is positiv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
Inventor 张云福裘建英
Owner SUZHOU FUYING GENE TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com